Dr. Haitham Shaheen | Oncology Awards | Best Researcher Award

Dr. Haitham Shaheen | Oncology Awards | Best Researcher AwardΒ 

Dr. Haitham Shaheen, Swansea bay university health board, United Kingdom

Dr. Haitham Shaheen is a highly accomplished medical oncology consultant with a distinguished academic and clinical background in oncology. Born on September 30, 1987, he currently serves as a Consultant in Medical Oncology at Somerset NHS Foundation Trust, UK, where he independently manages cancer patients, prescribes systemic anticancer therapies (SACT), and actively participates in multidisciplinary teams (MDTs). Previously, he held academic and clinical positions at Suez Canal University Hospital in Egypt, advancing from Assistant Lecturer to Consultant and Lecturer of Clinical Oncology. He holds an MD in Clinical Oncology, MRCP-UK, and certification from the European Society of Medical Oncology (ESMO). Dr. Shaheen has authored multiple high-impact publications on prostate cancer, pediatric lymphoma, and radiotherapy, and has presented his research internationally. A certified expert educator and active contributor to medical education and hospital training programs, he also held leadership roles in radiotherapy and digital transformation initiatives. His dedication to oncology, both clinically and academically, has earned him recognition for his contributions to research, education, and patient care.

Professional Profile:

SCOPUS

Summary of Suitability: Dr. Haitham Shaheen – Research for Best Researcher Award

Dr. Haitham Shaheen is a highly accomplished clinical oncologist and researcher whose work demonstrates a strong blend of academic rigor, clinical excellence, and impactful research in oncology. With dual MD degrees in Clinical Oncology, MRCP-UK, and ESMO certification, he possesses an exceptional academic foundation. His recent publications in high-impact journals such as Brachytherapy and the International Journal of Radiation Oncology, Biology, Physics reflect his deep engagement with evidence-based cancer treatment and translational research. Dr. Shaheen’s focus on prostate cancer outcomes and innovative treatment safety showcases a commitment to improving oncological care through research. In his current role as a consultant at the Somerset NHS Foundation Trust, he continues to integrate clinical practice with research, underscoring his suitability for the Best Researcher Award.

πŸŽ“ Education

  • 🩺 Bachelor of Medicine and Surgery – Suez Canal University, Egypt (Nov 2010)

  • πŸ“˜ MD in Clinical Oncology – Suez Canal University (March 2016)

  • πŸŽ“ MD (Highest Academic Medical Degree in Egypt) – Suez Canal University (March 2021)

  • πŸ‡¬πŸ‡§ MRCP (UK) – Royal College of Physicians (Jan 2022)

  • 🌍 ESMO Certificate – European Society of Medical Oncology (Nov 2022)

πŸ’Ό Work Experience

  • πŸ‘¨β€βš•οΈ Consultant, Medical Oncology – Somerset NHS Foundation Trust, UK (Sep 2023 – Present)

  • πŸ‘¨β€πŸ« Lecturer & Consultant, Clinical Oncology – Suez Canal University Hospital, Egypt (Mar 2021 – Sep 2023)

  • πŸ§‘β€βš•οΈ Assistant Lecturer & Specialist, Clinical Oncology – Suez Canal University Hospital (Mar 2016 – Mar 2021)

  • πŸ₯ Resident, Clinical Oncology – Suez Canal University Hospital (2012 – 2016)

  • 🩺 Internship – Suez Canal University Hospital (2011 – 2012)

πŸ† Achievements, Awards & Publications

  • πŸ“ First Author –

    • Voluntary DIBH with VMAT in Pediatric Hodgkin’s Lymphoma, Future Oncology Journal (Jan 2023)

    • Systematic Review on Prostate Cancer Outcomes, IJROBP (Red Journal) (Oct 2023)

  • 🀝 Co-author –

    • Safety of HDR Brachytherapy in Prostate Cancer, Brachytherapy Journal (Dec 2023)

    • Oncologist Perceptions on Cancer Patient Vaccination, IJCBR (Mar 2022)

    • Pediatric Radiotherapy Utilization Rate, Radiotherapy and Oncology (2021)

  • 🎀 Oral Presentations on VMAT and DIBH in Mediastinal Lymphoma

  • πŸ“… Conference Organizer & Secretary – 1st and 2nd Oncology Conferences, Suez Canal University (2018, 2019)

PublicationΒ Top Notes:

Safety of high-dose rate (HDR) brachytherapy for patients with prostate cancer and history of prior chemoradiation for rectal cancer: A case series

Dr. Dong Hyun Kim | Radiation oncology Award | Best Researcher Award

Dr. Dong Hyun Kim | Radiation oncology Award | Best Researcher Award

Dr. Dong Hyun Kim, Seoul National University College of Medicine, South Korea

Dong Hyun Kim, born on April 16, 1993, in South Korea, is a clinical researcher and physician specializing in clinical oncology, hematologic malignancy, and translational medicine. He is currently an external clinical researcher in the Division of Hemato-Oncology at Seoul National University Hospital. Dr. Kim earned his Bachelor of Medicine from Seoul National University College of Medicine in 2019, followed by a Master of Medical Science in Translational Medicine, expected in 2024. He has held positions as an intern and resident doctor in internal medicine at Seoul National University Hospital. Dr. Kim’s research has garnered numerous honors, including the Best Oral Presentation Awards at ICBMT 2022 and ICKSH 2024, as well as the prestigious Presidential Oral Presentation at JSMO 2024.

Professional Profile:

ORCID

SCOPUS

Summary of Suitability for Best Researcher Award: Dong Hyun Kim

Research Excellence: Dong Hyun Kim has demonstrated exceptional contributions to the fields of Clinical Oncology and
Hematologic Malignancy, focusing on translational medicine. His publication record showcases a robust output of 37
articles, with significant works in high-impact journals such as Cells, British Journal of Haematology, and Scientific Reports.
His research spans critical topics, including tumor microenvironments, therapeutic strategies, and the role of artificial
intelligence in oncology

Education:

πŸŽ“ Seoul National University College of Medicine, Seoul, Korea

  • Bachelor of Medicine (2015 ~ 2019)
  • Master of Medical Science, Department of Translational Medicine (2022 ~ 2024)

Professional Experience:

πŸ₯ Seoul National University Hospital

  • Intern (2019 ~ 2020)
  • Resident Doctor, Department of Internal Medicine (2020 ~ 2023)
  • External Clinical Researcher, Division of Hemato-Oncology (2023 ~ Present)

Honors & Awards πŸ…:

  • Best Oral Presentation Award, ICBMT 2022
  • Presidential Oral Presentation, JSMO 2024
  • Best Oral Presentation Award, ICKSH 2024

Publication top Notes:

Dual T-cell depletion with individually tailored anti-thymocyte globulin and attenuated dose of post-transplant cyclophosphamide in haploidentical peripheral stem cell transplantation

Phase II trial of posaconazole prophylaxis during anti-thymocyte globulin treatment for aplastic anaemia and hypoplastic myelodysplastic syndrome

Effects of tertiary palliative care on the pattern of end-of-life care in patients with hematologic malignancies in Korea

Impact of PIK3CA and cell cycle pathway genetic alterations on durvalumab efficacy in patients with head and neck squamous cell carcinoma: Post hoc analysis of TRIUMPH study

Predictive value of early dynamic changes of NLR and PLR for the efficacy of immune checkpoint inhibitor in head and neck squamous cell carcinoma